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2Abstract
The traditional static view of the adult mammalian brain has been challenged by the
realization of continuous generation of neurons from stem cells. Based mainly on studies
in experimental animals, adult neurogenesis may contribute to recovery after brain insults
and decreased neurogenesis has been implicated in the pathogenesis of neurological and
psychiatric diseases in man. The extent of neurogenesis in the adult human brain has,
however, been difficult to establish. We have taken advantage of the integration of 14C,
generated by nuclear bomb tests during the Cold War, in DNA to establish the age of
neurons in the major areas of the human cerebral cortex. Together with the analysis of the
cortex from patients who received BrdU, which integrates in the DNA of dividing cells,
our results demonstrate that whereas non-neuronal cells turn over, neurons in the human
cerebral cortex are not generated postnataly at detectable levels, but are as old as the
individual.
3Introduction
New neurons derived from endogenous stem or progenitor cells are continuously added
to the adult mammalian brain. This may be important for processes requiring plasticity,
such as memory formation (1), and new neurons have been suggested to replace lost cells
after stroke and other insults (2, 3). Furthermore, neurogenesis has been implicated in the
pathogenesis of human neurological and psychiatric diseases (4-7).
There is a considerable degree of plasticity in the cortex, enabling for example memory
formation (8), and there is evidence of structural alterations resulting in detectable
changes in volumes in distinct areas in the adult human cortex with age and in response
to certain conditions (9, 10). Much of the plasticity can be accounted for by modulating
pre-existing cells and their connections, but it is important to determine if neuronal
turnover may contribute to cortical plasticity in humans.
It has remained controversial whether neurons are added to the cerebral cortex in adult
mammals. Some studies have suggested that neurogenesis persists in the adult rodent (11,
12) and monkey cortex (13-15), whereas other studies have failed to detect neurogenesis
(16-18) or only in response to an insult (19, 20).
The most common way to detect neurogenesis is by the integration of labeled
nucleotides, such as BrdU, but there are inherent risks of both false positive and negative
results, making room for controversy (21, 22). Moreover, there are difficulties in
performing these types of studies in humans, and there is little BrdU labeled material
available for analysis. We have recently developed a new method to retrospectively
determine the age of cells in humans by measuring 14C in DNA (23). The entry of cosmic
rays into the atmosphere results in de novo generation of 14C, which is matched by
4radioactive decay (t1/2=5730 years), resulting in stable steady-state atmospheric levels. A
striking exception was caused by above ground nuclear bomb tests during the Cold War,
which produced an approximate doubling of 14C levels in the atmosphere from 1955 to
1963 that rapidly distributed around the globe (24, 25). After the 1963 Test Ban Treaty
there have been no significant above ground high yield nuclear detonations and the 14C
levels have decreased nearly exponentially (26), not because of radioactive decay, but
due to equilibration with the oceans and uptake in the biotope.  14C in the atmosphere
reacts with oxygen to form CO2 and is taken up by plants in photosynthesis. Our
consumption of plants and animals that live off plants, results in the 14C levels in the
human body mirroring those in the atmosphere at any given time (23, 27-29). Since DNA
is stable after a cell has gone through its last cell division, the 14C level in DNA serves as
a date mark for when a cell was born and can be used to retrospectively birth date cells in
humans (23).
Here we present a systematic analysis of cell turnover in the major areas of the human
cortex. We have retrospectively birth dated neurons by measuring the level of 14C and
analyzed the brains of individuals that received BrdU. We failed to detect BrdU labeled
neurons and report that cortical neurons have 14C levels corresponding to the atmospheric
levels at the time of birth of the individual.
5Results
We have measured the 14C concentration in DNA of cells in the major areas of the human
cerebral cortex by accelerator mass spectrometry. DNA was extracted from neurons and
non-neuronal cells, respectively, after flow cytometric sorting of nuclei incubated with an
antibody against the neuron specific nuclear epitope NeuN (Figure 1A). Flow cytometric
gates were set to ensure the inclusion of all nuclei irrespective of size in the different
populations, because adult born cortical neurons in the rodent have been reported to be
small (12). By comparing the measured 14C level in DNA to atmospheric concentrations
at different times, we can establish the average year of birth for the cell populations
(Figure 1B) (23).
14C levels in DNA of cerbral cortex cells from all lobes were analyzed, and the specific
areas are indicated in Figure 2A. Both prefrontal and premotor cortices were analyzed in
the frontal lobe. We first studied individuals born after the Cold War and the Test Ban
Treaty, since the decline in nuclear bomb test derived 14C in the atmosphere during this
period provides resolution as to when cells were born. Non-neuronal NeuN-negative cells
always had 14C levels that were lower than those in the atmosphere at the time of birth of
the individual, demonstrating cell turnover within this population (Figure 2B and
Supplementary Information). These cells were in average born 5.5±1.3 years
(mean±SEM, n=5 measurements) after the birth of the individual. In contrast, the 14C
levels in every analyzed sample of NeuN-positive neuronal nuclei from all individuals
and all cortical regions showed 14C levels corresponding to the time of birth of the
individual (Figure 2B and Supplementary Information). The cortical neurons were born
60.3±0.2 years (mean±SEM, n=5 measurements) before the birth date of the individual,
i.e. during the fetal period.
The strategy to birth date cells builds on the steep slope of 14C decline in the atmosphere
after the nuclear bomb tests. The resolution in time before the bomb tests is very poor.
However, the low levels of 14C before the bomb-pulse makes the detection of a small
population of cells born during or after the bomb tests especially sensitive, and a
population constituting as little as 1% of the total cell population over the lifespan can be
detected (23). 14C levels in DNA from NeuN-negative non-neuronal cells were invariably
higher than the pre-bomb levels in individuals born before the nuclear tests, again
demonstrating turnover within this population (Figure 2C and Supplementary
Information). However, as these 14C levels correspond to levels both at the time of
increasing and decreasing 14C levels, the turnover rate of these populations cannot be
inferred from these data alone. The 14C levels in DNA of NeuN-positive neurons, in
contrast, corresponded to the atmospheric levels prior to the nuclear bomb tests in all
samples from all cortical regions in all individuals born prior to 1955 (Figure 2C and
Supplementary Information). Thus, if there is any generation of stably integrating cortical
neurons during adulthood, they amount to less than 1% of the neuronal population up to
the age of 72 years (the oldest individual included in the 14C analysis).
The 14C analysis provides cumulative information about the age of cells, and about
potential cell turnover, over the life span of the individual. The analysis is therefore
sensitive for the detection of very low-grade continuous generation of new cells that
stably integrate and survive long term. However, if transitory cells are produced that are
not maintained, they would go unnoticed by this method if they constituted <1% of the
7cells at any given time. It has been suggested that neurons are generated in the adult
monkey cortex, but that they have a short life span and are transient (15). We next
analyzed the cortex of cancer patients that had received an injection of BrdU for
diagnostic purposes (30). The time of death ranged between 4.2 months and 4.3 years
after BrdU administration. As a positive control for the detection of adult born neurons,
we analyzed sections from the hippocampus from the same patients and were able to
detect cells double-labeled with BrdU and NeuN in the granular layer of the dentate gyrus
(30). In the negative control brains from individuals who did not receive a BrdU
injection, we were unable to detect any BrdU labeling (data not shown).
BrdU-positive cells were disproportionately distributed through the depth of the motor
cortex; 46% of the BrdU-positive cells were located in the white matter, and <1% to 17%
in the specific lamina (Figure 3A). We analyzed the identity of labeled cells in the frontal
and motor cortex by immunohistochemistry using antibodies against cell type specific
markers. Less than 1% of the BrdU-positive cells were glia-like satellite cells, and a small
subpopulation constituted GFAP-immunoreactive astrocytes (Figure 3B). Most
importantly, none of the BrdU labeled cells had neuronal morphology or was
immunoreactive to the neuronal markers NeuN or neurofilament. In cases where a BrdU-
positive nucleus was located in close proximity to a NeuN- or neurofilament-
immunorective neuron (n=515), three-dimensional confocal reconstruction was
performed to establish whether the labels co-existed in the same cell, but this was never
the case (see examples in Figure 3C and D). Thus, we conclude that neurons are not
generated in the adult human brain at levels detectable with the employed methods, and if
transient neurons are generated, they have a life span of less than 4.2 months.
8 Discussion
Our analysis revealed that neurons in the adult human cerebral cortex have 14C levels in
their genomic DNA corresponding to atmospheric levels at the time when the individual
was born and we failed to detect BrdU labeled neurons, arguing against postnatal cortical
neurogenesis in man.
It is important to underscore that both of our approaches to detect cell turnover in the
adult cortex have detection limits, and that we cannot exclude neurogenesis below this
level. Retrospective 14C birth dating gives a cumulative measure that provides a high
sensitivity to detect a low grade continuous generation of new cells, even if these cells
would only account for 1% of the neurons over the entire life span in the analyzed area
(23). However, this requires that the newborn cells integrate stably and are maintained. It
has been suggested that newborn neurons in the monkey cortex have a short life span and
are not maintained long term (15). If at any given time such neurons account for less than
1% of the neurons in the analyzed area, they would not be detectable by retrospective 14C
birth dating with the current sensitivity.
In this context, BrdU labeling has the advantage that it labels new born cells at a given
point in time, and it would be easy to detect very much less than 1% of neurons being
labeled at the time of analysis. The time period between BrdU administration and death
of the individuals we analyzed ranged between 4.2 months and 4.3 years. Our results thus
indicate that there can only be little (<1%), if any, stable integration of cortical neurons in
the adult human brain, and if there is a production of transitory neurons, they have a life
span of less than 4.2 months.
9Several studies have demonstrated the presence of cells with in vitro neural stem cell
potential in the human cortex, including in subcortical white matter (31). Our results do
not exclude the possibility that cortical neurogenesis may occur in certain pathologies or
that it may be possible to induce it, as has been suggested in the rodent cortex (19, 20,
32). There is no or minimal neurogenesis in the rodent striatum under normal conditions,
but large numbers of neurons are generated in response to growth factor administration or
stroke (2, 3, 33, 34). Although our current study indicates that cortical neurogenesis does
not take place in man under normal conditions, it will be important to analyze whether
there is a latent potential that results in neurogenesis in pathological situations.
There are clear species differences with regards to the extent of adult neurogenesis in
vertebrates. Large numbers of neurons may be added throughout life in fish (35).
However, fish often continue to grow throughout life, which could be viewed as a
continuation of development. Substantial numbers of new neurons, including both
interneurons and projection neurons, are added to several regions in birds such as zebra
finches and canaries (36). In rodents, interneurons are added to the dentate gyrus of the
hippocampus and to the olfactory bulb in mature animals (1). There are many reports
indicating more low-grade neurogenesis in other areas of the rodent brain, but many of
these studies await confirmation. The number of neurons that are added in the rodent
hippocampus and olfactory bulb decrease substantially with age, although neurogenesis
continues at low levels throughout life. One study demonstrated neurogenesis in the adult
human dentate gyrus (30), but it remains controversial whether neurons are added to the
adult human olfactory bulb (37, 38). Thus the distribution of adult neurogenesis appears
to have been gradually more restricted with evolution, although there is still limited
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information available regarding the extent and distribution of neurogenesis in the adult
human brain.
Plasticity is an important aspect of cortical function, and is necessary for example for the
integration of new memories. It is also easy to see the importance of stability for the
maintenance of memories, for example. There must be a delicate balance between
plasticity and stability, and the lack of human cortical neurogenesis suggests that cellular
stability has been favored, whereas other aspects of plasticity may have increased.
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Materials and Methods
Tissue collection
Tissues for 14C analysis were procured from cases admitted for autopsy during 2003 and
2004 to the Department of Forensic Medicine in Stockholm, with the consent of relatives.
Ethical permission for this study was granted by the Karolinska Institute Ethical
Committee. Tissue from seven individuals born between 1933 and 1973 (five individuals
born before and two born after the nuclear bomb tests), was analyzed for 14C content in
this study. The cause of death was chest trauma (n=1), hanging (n=4), electrocution (n=1)
or myocardial infarction (n=1). Tissues were frozen in 1 g samples and stored at –80°C
until further analysis.
Bromodeoxyuridine (250 mg in saline) was administered i.v. to assess the proliferative
nature of tumor cells in patients diagnosed with squamous cell carcinoma at the base of
the tongue, in the pharynx or larynx. Metastatic spread of the carcinomas was not seen in
the brain in any of these patients and no anti-cancer therapy was administered before,
during or shortly after BrdU administration.
Flow cytometry of nuclei
Nuclear isolation and flow cytometry were performed as described (23). NeuN antibodies
(39) were directly conjugated with Zenon mouse IgG labelling reagent (Alexa 488,
Molecular Probes). To ensure that only single nuclei were sorted, an aliquot of nuclei was
stained with DRAQ5 and the singlet population was plotted as a function of forward
scatter width (FSC-W) versus forward scatter height (FCS-H).  Using these parameters it
is easy to discriminate single nuclei from doublets, triplets and potential higher order
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aggregates as well as background noise (40). Nuclei were sorted based on purity, and the
purity of all sorts was confirmed by re-analyzing the sorted populations. ∆14C levels were
corrected when the purity was less than 100%. All FACS analysis and sorting was
performed using a FACS Vantage DIVA (BD). Nuclei pellets were collected by
centrifugation and stored at -80°C until extraction with NaI as described (23). DNA
purity for all samples was analyzed by spectrophotometry and HPLC.
Accelerator mass spectrometry
All accelerator mass spectrometry analyses were performed blind to age and origin of the
sample. Purified DNA samples suspended in water were transferred to quartz combustion
tubes and evaporated to dryness in a convection oven maintained at 90-95°C.  To covert
the DNA sample into graphite, excess CuO and silver wire were added to each dry
sample, the tubes were evacuated and sealed with a H2/O2 torch.  Tubes were placed in a
furnace set at 900°C for 3.5 h to combust all carbon to CO2. The evolved CO2 was
purified, trapped and reduced to graphite in the presence of iron catalyst in individual
reactors (41). Graphite targets were measured at the Center for Accelerator Mass
Spectrometry at Lawrence-Livermore National Laboratory and at the ANTARES AMS
Facility at the Australian Nuclear Science and Technology Organisation (42, 43).
Large CO2 samples (> 500 µg) were split and δ13C was measured by stable isotope ratio
mass spectrometry, which established the δ13C correction to –23 +/-2, which was applied
for all samples.  Corrections for background contamination introduced during sample
preparation were made following the procedures of Brown and Southon (44).  The
measurement error was determined for each sample and ranged between ±2-10‰ (1 SD)
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∆14C. All 14C data are reported as decay corrected ∆14C following the dominant
convention of Stuiver and Polach (1977).
Detection of BrdU and phenotypic markers
The brains from patients that received BrdU were removed and the cortex and
hippocampi were dissected, post-fixed in 4% paraformaldehyde for 24 h and then
incubated in 30% sucrose until equilibrated. Sections were cut on a freezing sledge
microtome in the coronal plane and the sections were stored in cryoprotective buffer
containing 25% ethylene glycol, 25% glycerin and 0.05 M phosphate buffer. Free-
floating sections were washed, incubated with HCl to denature DNA (45) and blocked 1
hour in 3% human and 3% horse serum. The sections were incubated with antibodies
against BrdU (1:200, Accurate), NeuN (1:50, Chemicon), neurofilament 200 (1:200,
Sigma) or GFAP (1:5000, Dako) for 48 h, then washed and incubated for 12 h in goat
anti-mouse alexa 488 and goat anti-rat alexa 594 (1:200 molecular probes). The sections
were then washed and mounted onto glass slides and coverslipped using Dako mounting
medium.
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Figure legends
Figure 1 Determination of the age of cortical neurons
Neuronal (NeuN-positive) and non-neuronal (NeuN-negative) cell nuclei from the adult
human cerebral cortex were separated and isolated by flow cytometry (A). The levels of
14C in the atmosphere have been stable over long time periods, with the exception of a
large addition of 14C in 1955-1963 as a result of nuclear weapons tests (blue line in B,
data from(46), making it possible to infer the time of birth of cell populations by relating
the level of 14C in DNA to that in the atmosphere (horizontal arrows) and reading the age
off the x-axis (vertical arrows). The average age of all cells in the prefrontal cortex is
younger than the individual (black arrows), indicating cell turnover. Dating of non-
neuronal cells demonstrates that they are younger, whereas neurons are approximately as
old as the individual. The vertical bar indicates the year of birth of the individual. 14C
levels from modern samples are by convention given in relation to a universal standard
and corrected for radioactive decay, giving the ∆14C value (47).
Figure 2 Cortical neurons are as old as the individual
(A) The cerebral lobes are outlined and the cortical area analyzed within each lobe is
color coded. Both prefrontal (blue) and premotor  (light blue) areas were analyzed in the
frontal lobe. The analysis of occipital cortex was reported in (23). (B) A representative
example of values obtained from one individual born after the nuclear weapons tests
plotted on to the curve of atmospheric 14C levels indicates that non-neuronal cells turn
over while the cortical neurons were generated close to the time of birth. (C) A
representative example of the analysis of an individual born before the nuclear tests,
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indicating no measurable cortical neurogenesis. The 14C level in the non-neuronal cells
demonstrates that there is turnover within this population, but there are several possible
interpretations of these data and the age of this population cannot be concluded from this
material alone.   The coloring of symbols in panels B and C corresponds to the regions in
A. Vertical bars in B and C indicate the birth date of the individual.
Figure 3 BrdU incorporation in the adult human cerbral cortex
(A) Distribution of BrdU labeled cells in the adult human motor cortex. A subset of BrdU
labeled cells are immunoreactive to the astrocyte marker GFAP (B). None of the BrdU
labeled cells are immunoreactive to the neuronal markers NeuN (C) or neurofilament (D).
The scale bars are 70 µm in B and 100 µm in C and D.
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Supplementary information
The direct data obtained from AMS came in the form of percent modern carbon, or pMC
values (as in column 5 from Table1). All data were determined using an isotopic
fractionation correction of –23 for DNA in human brain tissue.
For ease of presentation in graphical form, we derived the corresponding Δ14C  value
from the experimental pMC data. The term F14C refers to fraction of modern carbon
(defined in equation 2 from PJ Reimer, Radiocarbon, 46(3),1299-1304, 2004), and is
equivalent to pMC/100.
Δ14C was calculated using the following formula:
Δ14C = 1000 * {F14C * exp[λ*(1950 - y)] –1} where  λ = 1/8267 yr-1
To accurately represent these Δ14C data on the Levin data set graph, this value was decay
corrected. This was done to compensate for the small amount of radioactive decay of 14C
that will occur during the time of formation to measurement. This was done according to
the following equation (from Paula Reimer, personal communication):
Age corrected Δ14C  =  [e (2005-date of creation)/ 8267  * (AMS Δ14C  value +1000)] - 1000
The year of formation data was determined based on using the AMS values, and applying
them to the software provided on the freely accessible Calibomb website
(http://calib.qub.ac.uk/CALIBomb/frameset.html). All values are given in the table
below.
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A further important consideration regarding data analysis, is based on the purity
obtained from the flow cytometry stage. Given the fact, that the purity per sample is not
always 100%, this step aids in increasing interpretation accuracy. In the case where a
NeuN + and NeuN – sample are both available:
Solve for x (delta 14C NeuN+ population) and y (delta 14C NeuN- population):
(1) AMS value for delta 14C NeuN+  =   x (% FACS purity for NeuN+  )/100  + y(1 – %
FACS  purity for NeuN+)/100
(2) AMS value for delta 14C NeuN-  =    y (% FACS purity for NeuN-  )/100  + x(1 – %
FACS  purity for NeuN-)/100
In the case where one has the non sorted and either the NeuN + or NeuN- values, then the
third point can be determined by taking into account the percentage of the  NeuN+
population within that given sort. The NeuN- population will be the remaining percentage
(ie. 28% NeuN + within a given sort implies 72% NeuN- purity). Since, the non sorted
delta 14C value is known, the missing data point can be calculated.
26
Cortical Area SAMPLE ID# Patient # Population Percent Modern Carbon Delta 14C FACS Purity Correction Yr of Birth Yr 14C 
pMC Error Delta 14C ERROR Delta 14C corresponds to
(delta13C =-23)
PREFRONTAL
121400 18 Non Sort 108,76 0,50 80,25 5,020 80,25 1953,4 1956,0
121401 18 NeuN Pos 98,18 0,52 -24,79 5,225 -29,30 1953,4 1953,4
18 NeuN Neg 129,68 1953,4 1957,0
17 Non Sort 33,38 1952,0 1956,0
OZI344 17 NeuN Pos 98,07 0,73 -25,8 7,279 -26,90 1952,0 1952,0
OZI345 17 NeuN Neg 104,47 0,85 37,75 8,473 37,75 1952,0 1956,0
OZI397 14 Non Sort 139,32 0,84 383,9 8,311 383,90 1968,3 1974,7
OZI398 14 NeuN Pos 155,84 1,14 548,1 11,277 553,20 1968,3 1968,3
OZI399 14 NeuN Neg 138,06 1,12 371,4 11,167 365,10 1968,3 1975,5
OZI373 9 Non Sort 135,64 0,86 347,4 8,574 347,4 1973,3 1976,8
OZI374 9 NeuN Pos 143,37 1,01 424,2 9,999 427,70 1973,3 1973,1
OZI375 9 NeuN Neg 137,44 1,00 365,3 9,962 362,43 1973,3 1975,5
FRONTAL 
OZI340 17 Non Sort 107,28 0,54 65,7 5,4 65,7 1952,0 1956,0
OZI341 17 NeuN Pos 96,40 0,49 -42,4 4,9 -43,59 1952,0 1952,0
OZI342 17 NeuN Neg 105,32 0,57 46,2 5,7 48,03 1952,0 1956,0
22 Non Sort 26,32 1946,5 1955,0
121398 22 NeuN Pos 97,94 0,51 -27,3 5,1 -29,63 1946,5 1946,5
121399 22 NeuN Neg 105,45 0,79 47,3 7,9 48,08 1946,5 1957,0
120950 14 Non Sort 142,33 0,97 413,9 9,7 413,9 1968,3 1973,6
120951 14 NeuN Pos 157,31 1,16 562,6 11,6 566,6 1968,3 1968,3
120952 14 NeuN Neg 151,19 3,47 501,8 34,7 496,5 1968,3 1971,3
OZI361 27 Non Sort 104,20 0,63 35,1 6,2 35,1 1933,5 1956,0
OZI362 27 NeuN Pos 97,71 0,67 -29,4 6,6 -33,2 1933,5 1933,5
OZI363 27 NeuN Neg 103,64 0,69 29,5 6,9 29,5 1933,5 1955,0
PARIETAL 
OZI388 17 Non Sort 108,03 0,62 73,1 6,2 73,1 1952,0 1956,0
OZI389 17 NeuN Pos 96,44 0,98 -42,0 9,7 -44,39 1952,0 1952,0
17 NeuN Neg 115,2 1952,0 1957,0
OZI383 27 Non Sort 102,31 0,73 16,4 7,3 16,40 1933,5 1955,0
OZI384 27 NeuN Pos 97,42 0,67 -32,2 6,7 -38,09 1933,5 1933,5
OZI385 27 NeuN Neg 107,30 0,91 65,9 9,1 77,45 1933,5 1956,0
OZI377 22 Non Sort 108,22 0,72 75,0 7,2 75,00 1946,5 1956,0
OZI378 22 NeuN Pos 98,24 0,64 -24,1 6,3 -33,87 1946,5 1946,5
22 NeuN Neg 102,95 1946,5 1956,0
OZI332 23 Non Sort 100,19 0,48 -4,7 4,8 -4,70 1945,8 1954,0
OZI333 23 NeuN Pos 96,69 0,61 -39,5 6,1 -39,50 1945,8 1945,8
23 NeuN Neg 5,12 1945,8 1955,0
TEMPORAL 
120956 14 Non Sort 139,78 0,75 388,5 7,5 388,50 1968,3 1975,5
120957 14 NeuN Pos 164,70 1,95 636,1 19,5 644,66 1968,3 1967,2
120958 14 NeuN Neg 147,46 2,73 464,8 27,3 417,09 1968,3 1973,6
121408 22 Non Sort 105,80 0,43 50,8 4,3 50,80 1946,5 1956,0
121409 22 NeuN Pos 99,23 0,46 -14,4 4,6 -21,80 1946,5 1946,5
121410 22 NeuN Neg 106,08 0,49 53,6 4,9 53,70 1946,5 1956,0
OZI380 27 Non Sort 104,65 0,78 39,5 7,8 39,50 1933,5 1956,0
OZI381 27 NeuN Pos 99,26 0,86 -14,0 8,6 -17,40 1933,5 1933,5
27 NeuN Neg 61,62 1933,5 1956,0
OZI364 9 Non Sort 125,91 0,82 250,8 8,2 250,80 1973,3 1981,3
OZI365 9 NeuN Pos 141,16 0,99 402,2 9,8 420 1973,3 1973,2
OZI366 9 NeuN Neg 126,11 1,36 252,7 13,5 242 1973,3 1982,6
OZI349 23 Non Sort 102,76 0,37 20,8 3,7 20,8 1945,8 1955,0
OZI350 23 NeuN Pos 95,74 0,42 -49,0 4,2 -54,13 1945,8 1945,8
23 NeuN Neg 48,5 1945,8 1956,0
OZI370 18 Non Sort 109,47 0,64 87,5 6,4 87,5 1953,4 1956,0
OZI371 18 NeuN Pos 101,45 0,70 7,8 7,0 -1,29 1953,4 1953,4
OZI372 18 NeuN Neg 115,02 0,85 142,5 8,4 147,72 1953,4 1957,0
